Edition:
United Kingdom

Profile: Genomma Lab Internacional SAB de CV (LABB.MX)

LABB.MX on Mexico Stock Exchange

18.11MXN
3:02pm BST
Change (% chg)

$-0.07 (-0.39%)
Prev Close
$18.18
Open
$18.19
Day's High
$18.19
Day's Low
$18.00
Volume
53,509
Avg. Vol
1,959,153
52-wk High
$18.63
52-wk Low
$11.10

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Company Address

Genomma Lab Internacional SAB de CV

Edificio Samara
Antonio Dovali Jaime no. 70 Piso
Colonia Santa Fe
MEXICO, D.F.     01210
P: +5255.50810000
F: +5255.50810000

Company Web Links